Abstract

The opportunities provided by biotechnology and phytoengineering methods for producing physiologically active substances (secondary metabolites) of plant origin are considered. It is noted that alkaloids, flavonoids, terpenes, steroids, and other compounds of plant origin are of pharmaceutical interest and can be prepared using cellular technologies and plant cell and tissue culture.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.